On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayOct 03, 2022 11:30 am

D-Wave Quantum Inc. (NYSE: QBTS) Offers Quantum Computing Solutions to Help Enterprises Solve Optimization Business Challenges, Today

40% of large enterprises are already experimenting with quantum computing to solve some of their most complex problems, according to 451 Research Optimization problems make up a significant portion of the enterprise problem universe, and annealing quantum computers are uniquely effective at solving these types of problems D-Wave is the only provider building both annealing and gate-model quantum computers that provide opportunities for businesses looking to optimize at scale The classical computer architecture relies on binary coding, which assigns values of 0 or 1, limiting the decision-making process to a return result of one. The binary space cannot handle large…

Continue Reading

MondayOct 03, 2022 10:45 am

HeartBeam Inc. (NASDAQ: BEAT) Receives US Patent for Exclusive ECG Patch Monitor Designed to Detect Heart Issues

The USPTO issued a patent for BEAT’s 12-lead electrocardiogram (“ECG”) patch monitor for detection of ACS and cardiac arrhythmia HeartBeam has developed the only 3D-vector ECG platform for heart-attack detection anytime, anywhere BEAT’s patch technology could have a disruptive effect on the ECG patch market with its ischemia detection capability News about heart attacks and other life-threatening cardiovascular issues is alarming. Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States (https://nnw.fm/68lZq), and recent reports suggest that COVID-19 may cause heart problems (https://nnw.fm/oQ7Ax) and that the incidence of heart…

Continue Reading

MondayOct 03, 2022 10:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Focusing on Multiple Mainstream Applications of Its Disruptive Patented DehydraTECH(TM) Technology

Lexaria is the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technology DehydraTECH is designed to enhance the performance of fat-soluble active pharmaceutical ingredients (“APIs”), molecules, and drugs by increasing their bioavailability Through animal and human studies, Lexaria has shown that DehydraTECH increases the bioavailability of antiviral drugs, CBD, oral nicotine and more The company is focusing on multiple mainstream applications of its technology that rerrcould address serious unmet patient needs Lexaria is currently keen on developing a potential treatment for hypertension  Last summer, drug delivery platform innovator Lexaria Bioscience (NASDAQ: LEXX) announced a review of its successful 2021…

Continue Reading

MondayOct 03, 2022 9:20 am

Business Booming for Golden Matrix Group Inc. (NASDAQ: GMGI) as Online Gambling Continues Growth in Popularity

Data Bridge Market Research forecasts a 13.7% CAGR for the casino online gambling market to reach $144.74 billion in 2028 Golden Matrix Group is demonstrating growth in both its B2B and B2C businesses, as it prepares to enter the Mexican markets GMGI revenue for the first nine months of fiscal 2022 was $26.46 million, up 237% from a year earlier, while the company notched its 16th consecutive profitable quarter For decades, there was little substantial innovation in the gambling industry and then along came the miracle of the internet and changed everything with the emergence on online gaming. Still, most…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217